GlassScriptPhysician profile
Nisha S Patel
NPI 1336392547
$947.57
in general payments reported to CMS, 2019-2025
11 companies · $275 in 2025
The $275 reported for 2025 was less than what a typical Allergy & Immunology (Internal Medicine) provider received nationally (typical 2025 total: $681).
See the full distribution for Allergy & Immunology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2022: $80.83 · 2023: $17.61 · 2024: $62.65 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tosoh Bioscience, INC. | $382.00 | 2019 | |
| Ardelyx, INC. | $150.73 | 2024-2025 | Ibsrela |
| Inspire Medical Systems, INC. | $140.61 | 2025 | Inspire |
| Abbvie INC. | $99.99 | 2019 | |
| Kaleo, INC. | $37.26 | 2022 | |
| Orapharma, A Division of Bausch Health US, LLC | $35.11 | 2023-2025 | Arestin |
| Gilead Sciences, INC. | $28.59 | 2024 | |
| Glaxosmithkline, LLC. | $27.38 | 2022 | |
| Pharming Healthcare, INC. | $16.19 | 2022 | |
| Genentech USA, INC. | $15.00 | 2019 | |
| Allergan, INC. | $14.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nisha Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.